Garrett L Jensen1, Haijun Wu2, Dershan Luo3, Jennifer C Ho4, Pamela K Allen5, Tina M Briere3, Paul D Brown6, Jing Li5. 1. Department of Radiation Oncology, Baylor Scott & White, Temple, Texas, USA. 2. Head and Neck Malignancies Section, Department of Radiation Oncology, Xiangya Hospital, Central South University, Hunan Province, China. 3. Department of Radiation Physics, MD Anderson Cancer Center, Houston, Texas, USA. 4. Department of Radiation Oncology, Keck Hospital of USC, Los Angeles, California, USA. 5. Department of Radiation Oncology, MD Anderson Cancer Center, Houston, Texas, USA. 6. Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota, USA.
Abstract
PURPOSE: We present our institutional experience in treating brain metastases with GK-SRS and a headframe fixed to the skull with only 3 pins to avoid collisions between the headframe and the Gamma Knife (GK) machine. METHODS AND MATERIALS: Among 3500 consecutive patients who received GK-SRS in 2011-2017, 50 had 1 of the 2 anterior pins removed immediately before treatment of ≥1 brain lesion. Endpoints were local control, dosimetric parameters, and toxicity. RESULTS: Median follow-up time for the 49 patients with follow-up was 7.0 months (range 0.2-57.0). Median number of lesions treated per session was 6 (range 1-18); a median 1 lesion was treated with 3-pin fixation (range 1-2) and a median 5 lesions treated with 4-pin fixation (range 0-17) during the same session. Lesions treated with 3-pin fixation were in the occipital lobe (n=41), cerebellum (n=9), or temporal lobe (n=1). No local failures were noted. The sole grade 2 toxicity (partial seizure) was attributed to treatment of a 4-pin-fixed lesion. Except for gradient index, dosimetry did not vary for lesions treated with 3-pin versus 4-pin fixation. CONCLUSIONS: Treating brain metastases with 3-pin fixation did not compromise treatment outcome and is a good option for posterior brain metastases that cannot otherwise be treated with 4-pin GK-SRS.
PURPOSE: We present our institutional experience in treating brain metastases with GK-SRS and a headframe fixed to the skull with only 3 pins to avoid collisions between the headframe and the Gamma Knife (GK) machine. METHODS AND MATERIALS: Among 3500 consecutive patients who received GK-SRS in 2011-2017, 50 had 1 of the 2 anterior pins removed immediately before treatment of ≥1 brain lesion. Endpoints were local control, dosimetric parameters, and toxicity. RESULTS: Median follow-up time for the 49 patients with follow-up was 7.0 months (range 0.2-57.0). Median number of lesions treated per session was 6 (range 1-18); a median 1 lesion was treated with 3-pin fixation (range 1-2) and a median 5 lesions treated with 4-pin fixation (range 0-17) during the same session. Lesions treated with 3-pin fixation were in the occipital lobe (n=41), cerebellum (n=9), or temporal lobe (n=1). No local failures were noted. The sole grade 2 toxicity (partial seizure) was attributed to treatment of a 4-pin-fixed lesion. Except for gradient index, dosimetry did not vary for lesions treated with 3-pin versus 4-pin fixation. CONCLUSIONS: Treating brain metastases with 3-pin fixation did not compromise treatment outcome and is a good option for posterior brain metastases that cannot otherwise be treated with 4-pin GK-SRS.
Authors: Jennifer C Ho; Dershan Luo; Nandita Guha-Thakurta; Sherise D Ferguson; Amol J Ghia; James N Yang; Paul D Brown; Khinh Ranh Voong Journal: Neurosurgery Date: 2016-06 Impact factor: 4.654
Authors: Florian Stieler; Frederik Wenz; Beate Schweizer; Martin Polednik; Frank Anton Giordano; Sabine Mai Journal: Phys Med Date: 2018-07-06 Impact factor: 2.685
Authors: E Shaw; C Scott; L Souhami; R Dinapoli; R Kline; J Loeffler; N Farnan Journal: Int J Radiat Oncol Biol Phys Date: 2000-05-01 Impact factor: 7.038
Authors: Eric L Chang; Jeffrey S Wefel; Kenneth R Hess; Pamela K Allen; Frederick F Lang; David G Kornguth; Rebecca B Arbuckle; J Michael Swint; Almon S Shiu; Moshe H Maor; Christina A Meyers Journal: Lancet Oncol Date: 2009-10-02 Impact factor: 41.316